Status:

RECRUITING

Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Collaborating Sponsors:

Uganda Heart Institute

Conditions:

Rheumatic Heart Disease

Eligibility:

All Genders

5+ years

Phase:

NA

Brief Summary

The goal of this prospective study is to evaluate the feasibility, sustainability, and public health impact of a district-based program for secondary prevention of Rheumatic Heart Disease (RHD) in Uga...

Detailed Description

ADUNU is a non-randomized experiment, testing a strategy for implementing an evidence-based practice, decentralized RHD preventive services. The objectives of the study are to: Objective 1: Demonstr...

Eligibility Criteria

Inclusion Criteria:

  • residing in one of two involved districts in Uganda
  • providers at HCIIIs and HCIVs located in one of two involved Ugandan districts

Exclusion Criteria:

  • None

Key Trial Info

Start Date :

May 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2028

Estimated Enrollment :

221 Patients enrolled

Trial Details

Trial ID

NCT05783375

Start Date

May 1 2024

End Date

January 31 2028

Last Update

June 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Uganda Heart Institute

Kampala, Uganda, Uganda

Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda | DecenTrialz